Cargando…
Plasma repressor element 1-silencing transcription factor levels are decreased in patients with Alzheimer's disease
BACKGROUND: Repressor element 1-silencing transcription (REST)/neuron-restrictive silencer factor is considered a new therapeutic target for neurodegenerative disorders such as Alzheimer’s disease (AD). However, the relationship between AD and REST remains unclear. This study aimed to 1) examine pla...
Autores principales: | Wei, Mingqing, Ni, Jingnian, Shi, Jing, Li, Ting, Xu, Xiaoqing, Li, Chenmeng, Qin, Bin, Fan, Dongsheng, Xie, Hengge, Wang, Zhong, Wang, Yongyan, Lu, Tao, Tian, Jinzhou |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9158200/ https://www.ncbi.nlm.nih.gov/pubmed/35650520 http://dx.doi.org/10.1186/s12877-022-03163-8 |
Ejemplares similares
-
The Pattern Element Scale: A Brief Tool of Traditional Medical Subtyping for Dementia
por: Shi, Jing, et al.
Publicado: (2013) -
Plasma β-amyloid, tau, neurodegeneration biomarkers and inflammatory factors of probable Alzheimer’s disease dementia in Chinese individuals
por: Sun, Qingling, et al.
Publicado: (2022) -
Adding Chinese herbal medicine to conventional therapy brings cognitive benefits to patients with Alzheimer’s disease: a retrospective analysis
por: Shi, Jing, et al.
Publicado: (2017) -
Peripheral Blood and Cerebrospinal Fluid Levels of YKL-40 in Alzheimer’s Disease: A Systematic Review and Meta-Analysis
por: Zhang, Yuchen, et al.
Publicado: (2023) -
The efficacy and safety of Fufangdanshen tablets (Radix Salviae miltiorrhizae formula tablets) for mild to moderate vascular dementia: a study protocol for a randomized controlled trial
por: Tian, Jinzhou, et al.
Publicado: (2016)